| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 6, 2026 | Buy(P) | 488K | $25.61 | $12.5M | 1.4M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001012975-26-000235) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Lyell Immunopharma, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.